dockets: FDA-2025-P-4154

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2025-P-4154 FDA Request that the FDA determine whether Chewtadzy (tadalafil) Chewable Tablets, 5 mg, 10 mg, and 20 mg, approved under New Drug Application (NDA) number 218527, held by B Better, LLC, has been voluntarily withdrawn for reasons of safety or effectiveness Nonrulemaking 2026-04-22T20:47:39Z 0b000064b8fd6762

Links from other tables